LEADER 03874nam 2200577Ia 450 001 9910830347603321 005 20230721030846.0 010 $a1-281-06925-6 010 $a9786611069254 010 $a0-470-69198-0 010 $a0-470-76575-5 035 $a(CKB)1000000000404383 035 $a(EBL)320092 035 $a(SSID)ssj0000197962 035 $a(PQKBManifestationID)11179087 035 $a(PQKBTitleCode)TC0000197962 035 $a(PQKBWorkID)10161762 035 $a(PQKB)10670622 035 $a(MiAaPQ)EBC320092 035 $a(OCoLC)232611719 035 $a(EXLCZ)991000000000404383 100 $a20060607d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMarkers in cardiology$b[electronic resource] $ea case-oriented approach /$fedited by Jesse E. Adams 210 $aOxford $cBlackwell$d2007 215 $a1 online resource (274 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-3418-6 320 $aIncludes bibliographical references and index. 327 $aMarkers in Cardiology : A CASE-ORIENTED APPROACH; Contents; Contributors; Preface; Part 1 Cardiac troponins; 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation; 2 Diagnostic use of cardiac troponins in ST-segment elevation myocardial infarction; 3 Therapeutic implications of cardiac troponins in ST-segment elevation and non-ST-segment elevation myocardial infarction; 4 Ischemic heart disease in the absence of overt coronary artery disease; 5 So you think you have a ""false positive'' troponin? 327 $a6 Use of cardiac troponin in patients in non-ischemic pathologies and exposure to environmental toxins7 Cardiac troponins in patients with congestive heart failure; 8 Troponins and the critically Ill patient; 9 Cardiac troponins and renal failure; 10 Cardiac biomarkers: detection of in-hospital myocardial reinfarction; Part 2 Natriuretic peptides; 11 The future: interpreting new guidelines for myocardial infarction; 12 Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation,; 13 Natriruetic peptides in clinical practice 327 $a14 Outpatient evaluation for cardiovascular diseases using natriuretic peptide testing15 Natriuretic peptides in patients with renal failure; 16 Congestive heart failure: treatment implications of natriuretic peptides; 17 Utilizing multimarker strategies in patients who present with congestive heart failure; Part 3 Contemporary markers of risk; 18 Clinical integration of C-reactive protein for primary and secondary risk factor stratification; 19 Lipoprotein subfraction analysis using nuclear magnetic resonance spectroscopy; Index 330 $aWith the rapid development of the field of cardiac biomarkers comes a need for updated guidance on how to use them clinically. Drs. Adams, Jaffe, and Apple meet that need with this timely reference. Taking a case-oriented approach for the greatest clinical relevance, the book bridges the gap between science and practice. If you use - or want to use - cardiac markers such as BNP and troponin to help your patients, you will find this clear and comprehensive reference provides a dependable source of valuable information. The 19 chapters are divided into three parts: Cardiac Tr 606 $aHeart$xDiseases$xDiagnosis 606 $aBiochemical markers 615 0$aHeart$xDiseases$xDiagnosis. 615 0$aBiochemical markers. 676 $a616.1/24 676 $a616.12 701 $aAdams$b Jesse E$0863206 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830347603321 996 $aMarkers in cardiology$91926919 997 $aUNINA